VANCOUVER, British Columbia, Jan. 24 /PRNewswire-FirstCall/ -- The following was issued today by Robert Kramer, Director, Current Technology Corporation :
During 2005, Current Technology’s Singapore-based distributor Gromark Consumers Enterprise Pte. Ltd. identified a prospective sub-distributor in Taiwan (the “Sub-distributor”). Subsequent to receiving training in both Singapore and Vancouver, the Sub-distributor purchased four TrichoGenesis units and commenced a market evaluation.
The market evaluation has been completed successfully. The Sub-distributor has determined that in order to achieve its objective of becoming the premier hair solutions provider in Taiwan, formal medical approval would be required. Therefore, for the past several months, Current Technology (the “Company”) has been assisting the Sub-distributor in providing the regulatory authorities in Taiwan with data supporting the safety and efficacy of its TrichoGenesis platform. This process has involved the submission of numerous documents, which had to be certified by the Taiwanese authorities in Canada prior to delivery to Taipei. The Company believes the documentation process is substantially complete and the Sub-distributor advises a decision from the appropriate regulatory authority is anticipated by the end of March 2006.
The Company cannot predict the outcome of the regulatory process in Taiwan, but is confident a positive outcome will lead to significant sales in the near term. “The economy in Taiwan is robust,” states CEO Robert Kramer. “We are anxious to begin fulfilling the demand we believe awaits formal medical approval.”
About Current Technology Corporation
Current Technology Corporation remains committed to developing its non-invasive pulsed electro-stimulation technology. This technology has enabled the company to develop two separate and distinct products emanating from the TrichoGenesis platform, thus far, that offer help for those concerned with their hair: ElectroTrichoGenesis (ETG) and CosmeticTrichoGenesis (CTG). Current Technology holds patents throughout the world and has spent over US $15 million in research and development of its TrichoGenesis platform and systems. The patents encompass the technology, methodology and design of the Company’s products.
Current Technology Corporation
CONTACT: corporate, Robert Kramer of Current Technology Corporation,1-800-661-4247, or +1-604-684-2727, or rkramer@current-technology.com; orinvestor relations, Richard Hannon of Polestar Communications,+1-866-858-4100, for Current Technology Corporation
Web site: http://www.current-technology.com/